Quick Answer: Ordinary cosmetics do not automatically need TGA market authorisation. The first decision is whether the actual product is a cosmetic, a therapeutic good or a product covered by a relevant exclusion. Therapeutic goods can require an Australian Register of Therapeutic Goods pathway, with exceptions that need product-specific review. Neither a factory certificate nor an overseas approval settles this question for Australia.
MOOYAM editorial content. Last reviewed: 13 October 2026. Cover: AI-generated editorial illustration.
Why is “TGA approval” the wrong first question?
A beauty brand often encounters this phrase in supplier questionnaires before anyone has classified the product. That reverses the useful order of work. First define the product, its composition, use and presentation; then determine which framework applies. Only after that decision can the team identify the appropriate market-access requirements.
This article explains the approval question for international brand owners and importers. It is not a legal classification of your formula or an application guide for a particular medicine. For the wider project, start with our Australian cosmetic launch guide.
What does the therapeutic goods framework cover?
The Therapeutic Goods Act 1989, section 3 (official PDF) defines therapeutic goods by reference to therapeutic use, representations and other specified circumstances. It also contains exclusions and pathways that must be read alongside the definition. A product’s beauty positioning does not, by itself, determine whether the framework applies.
| Question | Relevant review | Decision needed |
|---|---|---|
| Is this a therapeutic good? | Therapeutic goods legislation and applicable instruments | Product-specific classification |
| Are cosmetic ingredients introduced? | Industrial chemicals framework | Introducing business and chemical pathway |
| Is retail ingredient information compliant? | Cosmetic information standard where applicable | Final packaging and retail presentation |
These workstreams should communicate, but they should not be collapsed into one certificate request. Ask your reviewer to state what has been assessed and what has not. A conclusion about a label is not necessarily a conclusion about chemical introduction, and a registration receipt is not proof that every advertising statement is appropriate.
When should the brand obtain specialist classification advice?
Obtain product-specific advice when the proposed purpose, claims or presentation creates uncertainty. Include the complete label, website copy, distributor descriptions and instructions. Reviewing only the front panel can miss important statements elsewhere. Give the reviewer the controlled formula version rather than a marketing description of the hero ingredient.
As a project control, create one claims sheet and keep its approved version with the formula brief. Distinguish what the product does cosmetically from any proposed therapeutic purpose. If a sales team later changes the copy, route the change back to the reviewer. Do not assume classification remains unchanged because the bottle itself looks the same.
Sun-protection, acne-related and other boundary products require particular care. Their classification cannot be inferred from a general blog overview. Do not launch a borderline product on the basis that another company’s apparently similar product is already on a marketplace.
Does AICIS registration mean the TGA has approved a product?
No. The Industrial Chemicals Act 2019 (official PDF) addresses industrial chemical introductions, including introducer registration and authorisation categories. It is a separate framework from therapeutic-goods market access. Keep the evidence and conclusions for those different requirements separately identifiable.
In a supplier review, avoid asking for “Australian registration” without naming the subject. Is the request about a business, a chemical introduction, a therapeutic product or a quality document? Precise language helps prevent a commercially plausible but irrelevant document from being accepted as the answer.
What documents help resolve the approval question?
| Input | What the reviewer needs to see | Common gap |
|---|---|---|
| Formula and relevant composition information | The product actually proposed for sale | A document for an earlier sample |
| Complete claims sheet | Packaging, online and distributor statements | Unreviewed advertising copy |
| Instructions and intended use | How and where the product is used | A vague “skincare” description |
| Relevant supporting evidence | Scope and applicability of test or technical records | Assuming a general report covers every claim |
| Supply route and responsible parties | Who imports, supplies and administers the pathway | Everyone assuming the factory handles it |
Classify missing information as unresolved, not as implicitly approved. Agree a confidential disclosure route where necessary. The technical contact at an OEM/ODM factory may need to communicate directly with the qualified reviewer rather than passing sensitive formula information through several purchasing intermediaries.
What can the cosmetic manufacturer provide?
The manufacturer can support the review with agreed ingredient information, COA, SDS, quality records, stability information, microbiological reports and packaging specifications where available and relevant. Those documents have individual scopes. Their existence does not establish a TGA authorisation or a legal conclusion about a therapeutic claim.
Ask which records cover the proposed formula and actual packaging. If the project changes, identify what must be revisited before production release. A supplier may offer documentation support without acting as the Australian sponsor, importer or regulatory consultant; define the service rather than assuming those roles are interchangeable.
What should the brand owner provide?
The brand should provide a complete commercial brief and the intended Australian presentation. Arrange the classification review and identify the local parties who will administer the applicable requirements. Keep the written conclusion accessible to marketing, purchasing and quality teams so later decisions do not contradict it.
For a practical launch file, record the product version, the evidence reviewed, the conclusion and any conditions. Include a named escalation contact. When the conclusion depends on specific wording or use, treat those conditions as controlled release requirements rather than optional suggestions for the design team.
A five-step decision process
- Freeze the actual formula, intended use and proposed claims.
- Arrange a classification assessment, including applicable exclusions.
- Identify the market-access pathway if therapeutic-goods regulation applies.
- Separately close applicable cosmetic ingredient and retail-information workstreams.
- Release only the reviewed product and copy; maintain change-control and records.
There is no universal timeline that can be quoted before the product and pathway are known. Technical gaps, changing claims and unresolved roles can delay the project. Build the schedule around verified milestones rather than a promise that one certificate will complete every Australian requirement.
FAQ
Do all cosmetics need TGA approval?
No. Determine whether therapeutic-goods regulation applies to the actual product before selecting a pathway.
Can an overseas approval replace Australian review?
Do not assume so. Australian classification and applicable requirements need their own assessment.
Is a factory GMP certificate a TGA product approval?
No. A manufacturing-quality document and product market access are different matters.
Can changing an advertising claim matter?
Yes. Product representations are relevant to the classification question. Review changes before using them.
Can MOOYAM make the legal decision for my brand?
Manufacturing and technical handover support should be distinguished from product-specific legal or regulatory advice.
Discuss your manufacturing documentation needs
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. See our OEM/ODM service and Australian brand sourcing overview, or contact the team about your formula and packaging brief.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.